Leukotriene D4, a potent biologically active lipoxygenase derivative of arachidonic acid in activated leukocytes, depresses the glomerular capillary ultrafiltration coefficient (Kf) and contracts mesangial cells in culture. We therefore investigated its potential role in mediating the reduction in nephron filtration rate seen after induction of experimental nephrotoxic serum (NTS)-induced glomerulonephritis in the rat. Micropuncture measurements were performed in euvolemic MunichWistar rats 2 h after i.v. administration of 0.8 ml of rabbit serum (group 1, n = 6), 0.8 ml of rabbit anti-rat glomerular basement membrane antibody in the absence (group 2, n = 8), or presence (group 3, n = 7) of the new highly specific LTD4 receptor antagonist SK&F 104353. Quantitation of antibody binding and neutrophil infiltration revealed no differences between groups 2 and 3. Antagonism of endogenous LTD4 actions, however, was associated with prevention of the NTS-induced fall in SNGFR because of the abrogation of the fall in Kf which characterizes this form of experimental glomerulonephritis. Antagonism of endogenous LTD4 had no effect on the NTS-induced increases in pre-and postglomerular arteriolar resistances, and did not affect nephron plasma flow rate or net transcapillary hydraulic pressure difference. The observed highly localized protective action of the LTD4 antagonist on the glomerular capillary points to a possibly major functional role for intraglomerularly released LTD4, likely originating from infiltrating leukocytes, in the pathophysiology of this form of glomerulonephritis.
Introduction
Glomerulonephritis remains a principal cause of acute and chronic renal failure in people, accounting for a substantial proportion of patients afflicted with end-stage renal disease. Despite considerable advances in the understanding of the immunologic mechanisms involved in the initiation and progression of this type of renal injury, less is known regarding the mediators of the functional derangements of glomerular perfusion and filtration observed during the course of this dis-orders. The model of nephrotoxic serum (NTS)'-induced glomerulonephritis, produced in the rat by the administration of antibody directed against glomerular basement membrane (GBM) antigens (anti-GBM), has proved to be a highly useful tool for evaluating the pathogenesis of glomerulonephritic injury (1) . Induction ofthis form of injury in the Munich-Wistar rat, uniquely endowed with surface glomeruli accessible to direct measurement of glomerular dynamics, has allowed previous investigators to describe the pattern of glomerular microcirculatory derangements underlying the depressed filtration rates observed during the acute (heterologous) (2, 3) as well as delayed (autologous) (4) phases of this experimental model. Consensus has emerged from the studies of Blantz and his co-workers (2, 3) , as well as those of Maddox et al. (4) , performed 1-2 h and 5-16 d after NTS administration, respectively, that the principal factor accounting for the fall in filtration rates in these animals was a marked reduction in the glomerular capillary ultrafiltration coefficient (Kf). The mediator mechanisms involved in the depression of Kf, however, remain unknown. Of interest, the sole experimental maneuvers resulting in some amelioration of the fall in Kf, as well as prevention of the accompanying proteinuria, were those associated with inhibition of glomerular leukocyte infiltration (5) (6) (7) (8) .
Recently, we have identified the glomerular microcirculatdry actions ofa relatively novel class ofvasoactive oxygenated derivatives of arachidonic acid, the peptidoleukotrienes (9, 10) . These products of the 5-lipoxygenase pathway are now recognized as constituting a major component of leukocytemediated inflammatory and allergic reactions (1 1, 12) . In particular, leukotriene D4 (LTD4) causes constriction of the efferent arteriole, with a secondary fall in single-nephron plasma flow rate (QA) and rise in glomerular transcapillary hydraulic pressure difference (AP). Despite the latter, single-nephron GFR (SNGFR) is reduced due to a dramatic fall in Kf(I0). We were struck by the similarity ofthese responses to exogenously administered LTD4 to the pattern of glomerular hemodynamics observed during the acute phase of NTS-induced injury (2, 3, 5) . In the present study, therefore, we employed a specific LTD4 receptor antagonist recently developed at Smith, Kline and French Laboratories (13) (14) (15) to investigate the possibility of a role for this pro-inflammatory white cell product in mediating some of the functional components of this form of acute experimental glomerulonephritis. 
Micropuncture studies
All experiments were performed on anesthetized adult male MunichWistar rats weighing 200-260 g which were prepared for micropuncture according to protocols described previously (17) . In brief, following Inactin anesthesia (Byk, Federal Republic ofGermany, 100 mg/kg, i.p), the left femoral artery was catheterized with PE 50 tubing (Clay Adams, Parsippany, NJ) which was used to monitor mean systemic arterial pressure (AP) by means of a pressure transducer (P23Db, Statham Instruments) connected to a direct writing recorder (Gould Instruments Inc., Cleveland, OH) and for sampling of blood.
After a tracheostomy, polyethylene catheters were inserted into both jugular veins for infusion ofplasma and a solution ofinulin (7.5% in 0.9% NaCI), and para-aminohippurate (PAH) (0.32 mg/min) at 1.2 ml/h. The left kidney was exposed by a left subcostal incision, separated from the surrounding fat, and suspended on a Lucite holder. The kidney surface was illuminated with a fiberoptic light source and bathed with isotonic NaCl. Homologous rat plasma was administered intravenously at a rate of 10 ml/kg. h for 45 min followed by a reduction in infusion rate to 1.5 ml/kg. h for the remainder of the experiment. This protocol of plasma administration has been shown previously to adequately replace surgically-induced plasma losses, thus maintaining euvolemia (17) .
In all experiments, micropuncture measurements were started 100-120 min after the administration of either decomplemented rabbit serum or NTS (see below) and carried out as follows: exactly timed (1-2 min) samples of fluid were collected from surface proximal convolutions of each of three to four nephrons for determination of flow rate and inulin concentration and calculation oftubule fluid-to-plasma inulin concentration ratio and SNGFR. Coincident with these tubule fluid collections, two or three samples of femoral arterial blood were obtained in each period for determination ofsystemic arterial hematocrit and plasma concentration of total protein and inulin. Also, at least three samples of blood were obtained from surface efferent arterioles (star vessels) for determination of immediate postglomerular plasma protein concentration. In addition, two or three samples of urine from the experimental kidney were collected for the determination of flow rate, protein concentration, inulin concentration, and for the calculation of whole-kidney GFR. For these urine collections, indwelling polyethylene ureteral catheters (PE 10) were used. Group I (n = 6). In this group of rats, 0.8 ml of decomplemented rabbit serum, the vehicle for NTS, was administered intravenously after cannulation of the jugular veins and a 0.9% NaCi solution, serving as vehicle for the LTD4 antagonist, SK&F 104353, was infused at 1.0 ml/h for the remainder of the experiment.
Group IA (n = 3). In these animals, the effect of administering the LTD4 antagonist alone on systemic and renal hemodynamics was tested. Thus, rats received decomplemented rabbit serum in combination with SK&F 104353 given as an initial bolus of 10 mg/kg and Leukotriene D4 in Nephrotoxic Nephritis 1703 followed by a continuous intravenous infusion of I mg/kg. h (I ml/h) for the remainder of the experiment.
Group II (n = 8). In these animals, cannulation of the jugular veins was immediately followed by administration of 0.8 ml of NTS. This was accompanied (in five rats) by initiation of an infusion of 0.9% NaCl at I ml/h for the remainder of the experiment, again serving as vehicle control for SK&F 104353.
Group III (n = 7). These rats received NTS as in group II, but were also treated with SK&F 104353, given as described for group IA.
Group III A (n = 6). These animals were prepared for surgery as described above, but, additionally, an electromagnetic flow probe was placed around the left renal artery and connected to a flow meter (Carolina Medical Instruments, Inc., King, NC) whose output was coupled to a third channel ofthe Gould recorder for continuous monitoring of renal blood flow. Also, a 30-gauge needle was inserted at the take-off of the left renal artery from the abdominal aorta through which an infusion of0.9% NaCl was started at a rate of0.05 ml/min. In this group ofanimals, the efficacy ofSK&F 104353 in antagonizing the systemic and renal actions of exogenously administered LTD4 was tested. Animals received intrarenal arterial LTD4 in a dose of I ,Ag/kg. min for 15 min in the presence (n = 3) and absence (n = 3) of SK&F 104353 given as described above prior to LTD4 administration. Analytical
Colloid osmotic pressures of plasma entering and leaving glomerular capillaries were estimated from values for protein concentrations (C) in femoral arterial (CA) and surface efferent arteriolar (CE) blood plasmas. Colloid osmotic pressure (r) was calculated according to the equation derived by Deen et al. (18) . Values for CA, and thus 'WA, for femoral arterial plasma are taken as representative for values for C and ir for the afferent end of the glomerular capillary network. These estimates of pre-and postglomerular protein concentration permit calculation of single-nephron filtration fraction (SNFF) and glomerular capillary ultrafiltration coefficient (Kf), as well as resistances of single afferent (RA) and efferent (RE) arterioles, and initial glomerular plasma flow rate (QA) by using equations described in detail elsewhere (18) .
The volume of fluid collected from individual proximal tubules was estimated from the length of the fluid column in a constant bore capillary tube ofknown internal diameter. The concentration ofinulin in tubule fluid was measured by the microfluorescence method of Vurek and Pegram (19) . Inulin concentrations in plasma and urine were determined by the macroanthrone method of Fuhr et al. (20) . Protein concentration in efferent arteriolar and femoral arterial blood plasmas were determined using the fluorometric method of Viets et al. (21) .
Urinary protein concentration was determined using the Coomassie Brilliant Blue method (22) .
Statistical
The significance of the differences in all the measured parameters among the three principal groups was assessed using two-way analysis of variance. Differences were considered significant at a P value < 0.05. All values are reported as mean±SEM.
Results
Morphologic examination and neutrophil quantitation. The dose ofNTS administered resulted in a mean concentration of 248 pg of antibody bound per glomerulus with a variance of < 20% among animals. Duplicate animals injected with NTS and killed 2 h later demonstrated a mean number of glomerular neutrophils equaling 4.1±0.2 neutrophils per glomerulus, compared with 0.2±0.1 per glomerulus for control animals. Rats receiving NTS in the presence of SK&F 104353 had significantly more neutrophils, 5.6±0.4 per glomerulus, than control nephritic rats. In this last group, glomerular neutrophils were readily identifiable on electron microscopic analysis as well. Fig. 1 illustrates a glomerular capillary loop in a rat receiving SK&F 104353 and killed 2 h after the intravenous injection ofNTS. Two polymorphonuclear leukocytes are seen flanking an endothelial cell, which appears partly displaced.
Micropuncture studies. The pattern of systemic, wholekidney, and glomerular microcirculatory hemodynamic parameters observed 2 h after administration of decomplemented rabbit serum (group I) was similar to that previously established for baseline control values in the euvolemic Munich-Wistar rat (17) and is presented in the top panels ofTable I. Additionally, the administration of SK&F 104353 alone to these rats (group IA) was without effect on any of the parameters measured: GFR, 1.03±0.05 ml/min; renal plasma flow (RPF) (PAH clearance), 4.1±0. 4 . Despite the persistently depressed ERPF, however, the GFR of group III rats was significantly greater than that of group II animals (0.92±0.10 vs. 0.61±0.07 ml/min, P < 0.025) and statistically not different from that of group I controls (0.92±0.10 vs. 1.07±0.05 ml/ minm P > 0.05). Thus, FF in this group ofanimals was elevated to 0.32, a value significantly higher than that ofgroup II rats (P < 0.005). In parallel with these changes in whole-kidney GFR, ERPF, and FF, single-nephron measurements revealed a fall in SNGFR, QA, and SNFF in group II rats as compared with group I controls (24.8±3.9 vs. 40.4±1.5 nl/min, P < 0.005; 89± 13 versus 126± 10, P < 0.05; and 0.27±0.02 vs. 0.33±0.02, P < 0.05, respectively). Similarly, the presence of the LTD4 receptor antagonist in group III animals was associated with a selective preservation of SNGFR (mean value 40.5±5.0 nl/ min, P < 0.025 vs. group II and P > 0.05 vs. group I) while QA remained depressed at 93±11 nl/min, a value significantly less than that ofgroup I animals (P < 0.05), but not different from that of group II rats.
Hydraulic pressure measurements in glomerular capillaries, proximal tubules, and efferent arterioles revealed that induction of acute NTS-induced glomerular injury was associated with elevation ofPGc (58±2 mmHg in group II vs. 46±1 mmHg in group I, P < 0.005), a change not significantly modified by the presence of SK&F 104353 in group III rats (52 mmHg, P > 0.05 vs. groups I and II). No significant differences in PT were observed among the three groups of animals (13±1 mmHg in group I, 12±1 mmHg in group II, and 111 ± mmHg 
Discussion
Mediators of glomerular inflammatory injury have been the subject of extensive research. Examination of the roles of vasoactive peptides and catecholamines (23) , the complement cascade (3, 6) , Hageman factor-related systems (1), oxygen metabolites (24, 25) , cyclooxygenase products (26) , and other mediators (27) of injury has led to the realization that impairment of glomerular filtration and permselectivity functions is the end result of highly complex interactions among these various systems. Despite much controversy regarding the contribution ofeach ofthe mediators involved, consensus exists as to Assessment of the roles played by various eicosanoids during experimental glomerulonephritis has employed two principal methodologic approaches: (a) measurement of endogenous or stimulated eicosanoid synthesis from renal venous effluents or from glomeruli freshly isolated from nephritic kidneys and (b) examination of the effects of selective eicosanoid antagonism through the use of specific enzyme inhibitors and/or receptor antagonists on the histopathologic or pathophysiologic expression of the disease process. In the present studies, we employed the latter approach to examine the role of the peptidyl leukotriene, LTD4, in a model of acute inflammatory glomerular disease. Detection and measurement ofendogenous production rates of peptidoleukotrienes is still frought with major methodologic difficulties (28) (29) (30) . The advantages of the model chosen include the induction of a reproducible, well-characterized, inflammatory reaction within a relatively short time (2-3 h) after administration of NTS, thus allowing for micropuncture measurements, and the relative stability and homogeneity of the glomerular histologic and functional lesions, thus validating the measured singlenephron parameters (2, 31) . That SK&F 104353 is indeed a potent and specific receptor antagonist of LTD4 is based on a number of published reports demonstrating that this structural analogue of LTD4 is capable of antagonizing and reversing its effects in a number of tissues including human and guinea pig lung (14) , rat basophilic leukemia cells (13) , and, in our present study, renal vasculature. In those systems where it has been tested, SK&F 104353 was found to specifically compete with [3H]LTD4 for binding to whole cells (13) (14) (15) , as well as cell membrane fractions (13) (14) (15) , and to effect a rightward shift of the dose-response curve of LTD4-mediated hydrolysis of phosphatidylinositol and intracellular calcium mobilization in a highly potent and specific manner (13) (14) (15) . Of particular relevance to the present observations is our recent demonstration of the presence of specific LTD4 binding sites on cultured rat glomerular mesangial cells, and of the capacity of SK&F 104353 to competitively inhibit ligand binding to these cells (32) .
In the present studies, acute administration of SK&F 104353 during induction of NTS-induced glomerular injury was without effect on the degree of antibody binding, as well as the number of infiltrating leukocytes in the glomeruli of the affected kidneys. This finding is hardly surprising in view of the notion that LTD4 is devoid of chemotactic activity and the consequences of its release on intrarenal hemodynamics, expected to occur at 2-3 h after antibody administration, should not affect the initial binding of the antibody to the glomerular basement membrane. Furthermore, recent studies by Yared et al. (33) have demonstrated independence of glomerular antibody binding from the prevailing hemodynamics. The continued demonstration of significant leukocyte infiltration in SK&F 104353-treated rats is of particular interest since, in the light of the present data, it suggests that the mere physical presence of leukocytes per se may not represent a major pathway of functional impairment. Clearly, however, as evidenced by the results of previous studies (1-6, 16, 34) as well as the present experiments, the biological consequences of leukocyte adherence and activation (such as cytokine release) play a central role in mediating the observed functional derangements (see below).
The capacity of NTS to reduce GFR is a dose-dependent phenomenon. In previous studies by Blantz et al. (3) , it was shown that the elevation in AP can counterbalance the reductions in QA and Kf, thus maintaining GFR, when relatively low doses of antibody are administered. It was our intention in the present study, however, to effect a significant reduction in GFR. Hence, the administered dose of our particular NTS batch was titrated to produce such an effect, and also to result in significant proteinuria at 2 h, as previously reported in this model (2, 3, 6, (34) (35) (36) . The principal mechanism underlying the fall in GFR and FF was clearly the markedly reduced Kf since the fall in QA caused by arteriolar vasoconstriction was offset, to a large degree, by the rise in AP. In this regard, the fall in ERPF and QA induced by NTS was due to combined increases in both RA and RE, as previously reported by others (2) (3) (4) . The proportionately greater rise in postglomerular resistance resulted in the rise in PGC and AP. Antagonism of LTD4 was without significant effect on these NTS-induced changes in arteriolar resistances, and did not improve ERPF, thus indicating that other locally released hormones may mediate this effect. In this regard, Lianos et al. (26) (41, 42) have confirmed the capacity of 5-lipoxygenase inhibitors to abrogate NTS-induced proteinuria, and studies by Mune and others (43) have demonstrated the presence of a strong correlation between glomerular LTC4 synthesis and the level of proteinuria in this model of glomerular injury.
In summary, these studies present strong evidence suggest- SNGFR is diminished due mainly to a reduction in Kf, likely related ing that LTD4, a highly potent cytokine released from activated leukocytes, plays an important role in mediating the reduction in GFR observed during experimental glomerular inflammatory injury. The effect of LTD4 appears to be highly localized within the glomerulus and is likely expressed through reductions in the glomerular filtering surface area. These observations may provide insight into the mechanisms underlying the tight linkage between leukocyte infiltration and functional impairment which characterizes this form of experimental glomerulonephritis.
